В. С. Косоруков

582 total citations
62 papers, 386 citations indexed

About

В. С. Косоруков is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, В. С. Косоруков has authored 62 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 22 papers in Immunology and 18 papers in Oncology. Recurrent topics in В. С. Косоруков's work include Immunotherapy and Immune Responses (16 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Transgenic Plants and Applications (8 papers). В. С. Косоруков is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Transgenic Plants and Applications (8 papers). В. С. Косоруков collaborates with scholars based in Russia, United States and Spain. В. С. Косоруков's co-authors include Yuri L. Dorokhov, Tatiana V. Komarova, Olga Frolova, Yuri Gleba, Anastasia V. Shindyapina, Ekaterina V. Sheshukova, Vladimir N. Smirnov, Т. А. Богуш, Sergey Paushkin and Vitaly V. Kushnirov and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

В. С. Косоруков

47 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
В. С. Косоруков Russia 11 228 92 74 70 56 62 386
Hyun‐Ho Kyeong South Korea 10 229 1.0× 40 0.4× 26 0.4× 26 0.4× 33 0.6× 13 329
Di Guan China 11 267 1.2× 33 0.4× 69 0.9× 51 0.7× 27 0.5× 28 526
Yasuyuki Matsumoto United States 15 356 1.6× 180 2.0× 69 0.9× 19 0.3× 54 1.0× 36 563
Stéfanie Schneider Germany 11 230 1.0× 99 1.1× 85 1.1× 13 0.2× 14 0.3× 13 485
Victor G. Sendra United States 12 183 0.8× 167 1.8× 59 0.8× 17 0.2× 114 2.0× 34 460
Hsiu‐Ping Lin Taiwan 12 248 1.1× 36 0.4× 54 0.7× 46 0.7× 11 0.2× 24 375
Emily Y. Yang United States 5 149 0.7× 62 0.7× 65 0.9× 13 0.2× 128 2.3× 6 321
Vineet Sangar United States 11 290 1.3× 39 0.4× 106 1.4× 15 0.2× 13 0.2× 18 497
Elsy M. Ngwa Switzerland 6 553 2.4× 180 2.0× 32 0.4× 26 0.4× 12 0.2× 7 643
Andrea Delpino Italy 12 238 1.0× 71 0.8× 60 0.8× 14 0.2× 25 0.4× 40 439

Countries citing papers authored by В. С. Косоруков

Since Specialization
Citations

This map shows the geographic impact of В. С. Косоруков's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by В. С. Косоруков with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites В. С. Косоруков more than expected).

Fields of papers citing papers by В. С. Косоруков

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by В. С. Косоруков. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by В. С. Косоруков. The network helps show where В. С. Косоруков may publish in the future.

Co-authorship network of co-authors of В. С. Косоруков

This figure shows the co-authorship network connecting the top 25 collaborators of В. С. Косоруков. A scholar is included among the top collaborators of В. С. Косоруков based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with В. С. Косоруков. В. С. Косоруков is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, A., et al.. (2024). Characterization of Non-Small Cell Lung Cancer Tissue by Quantitative Assessment of Class III β-Tubulin Expression. SHILAP Revista de lepidopterología. 69(5-6). 28–34.
2.
Pokrovsky, Vadim S., et al.. (2024). Human Metastatic Melanoma Cell Lines Panel for In Vitro and In Vivo Investigations. SHILAP Revista de lepidopterología. 5(1). 11–27. 2 indexed citations
4.
Вартанян, А. А. & В. С. Косоруков. (2023). Melanoma Cell Lines as a Basis for Development of a Model of Vasculogenic Mimicry. Biology Bulletin. 50(3). 259–265.
5.
Pokrovsky, Vadim S., et al.. (2023). Bioresource collections: algorithms for development and functioning; basic and applied significance. CARDIOVASCULAR THERAPY AND PREVENTION. 22(11). 3654–3654. 3 indexed citations
6.
Шевченко, В. Е., V. G. Kucheryanu, В. С. Косоруков, et al.. (2023). Secondary Metabolites of Oplopanax elatus: Possibilities for Standardization of a Multiphytoadaptogen for Preventive Oncology. Pharmaceutical Chemistry Journal. 57(1). 75–82. 2 indexed citations
7.
Бочарова, О. А., В. Е. Шевченко, V. G. Kucheryanu, et al.. (2022). Computer‐aided Evaluation of Polyvalent Medications’ Pharmacological Potential. Multiphytoadaptogen as a Case Study. Molecular Informatics. 42(1). e2200176–e2200176. 3 indexed citations
8.
Косоруков, В. С., et al.. (2022). Comparison of Ridostin Pro and Poly(I:C) as adjuvant for a cancer neoantigen peptide vaccine. Russian Journal of Biotherapy. 21(3). 82–89.
9.
Косоруков, В. С., et al.. (2022). Tafalgin is a Russian innovative tetrapeptide pharmaceutical for subcutaneous injection: review of the results of phase I and II clinical trials. SHILAP Revista de lepidopterología. 12(2). 89–107. 10 indexed citations
10.
Богуш, Т. А., et al.. (2021). Correlation of quantitative measures of estrogen receptor α and β expression in non-small cell lung cancer tissue with clinical characteristics of the disease. SHILAP Revista de lepidopterología. 66(5-6). 23–29. 1 indexed citations
11.
Косоруков, В. С., et al.. (2021). Effect of Poly(I:C) and melanoma B16-F10 on the immunophenotype of murine spleen cells. Russian Journal of Biotherapy. 20(4). 51–58. 1 indexed citations
12.
Косоруков, В. С., et al.. (2020). Pyroptosis as Inflammatory Cell Death. SHILAP Revista de lepidopterología. 13(2). 129–135. 2 indexed citations
13.
Богуш, Т. А., et al.. (2020). Immunofluorescent Assay of De Novo Vimentin Expression in Ovarian Cancer Tissues: Surgical Specimens vs Paraffin Embedded Tissue Blocks. Moscow University Chemistry Bulletin. 75(6). 315–319. 1 indexed citations
14.
Косоруков, В. С., et al.. (2019). EVALUATION OF THE ANTITUMOR EFFICACY OF SYNTHETIC NEOANTIGEN PEPTIDES FOR THE MELANOMA VACCINE MODEL. Russian Journal of Biotherapy. 18(4). 76–81. 5 indexed citations
15.
Косоруков, В. С., et al.. (2019). Identification of immunogenic mutant neoantigens in the genome of murine melanoma. Russian Journal of Biotherapy. 18(3). 23–30. 5 indexed citations
16.
Косоруков, В. С., et al.. (2018). Neoantigens in tumor immunotherapy. Russian Journal of Biotherapy. 17(2). 6–14. 7 indexed citations
17.
Косоруков, В. С., et al.. (2018). Cancer vaccine adjuvants. Russian Journal of Biotherapy. 17(4). 36–44. 2 indexed citations
18.
Komarova, Tatiana V., et al.. (2011). Plant-Made Trastuzumab (Herceptin) Inhibits HER2/Neu+ Cell Proliferation and Retards Tumor Growth. PLoS ONE. 6(3). e17541–e17541. 38 indexed citations
19.
Frolova, Olga, Tatiana V. Komarova, В. С. Косоруков, et al.. (2010). Trastuzumab-binding peptide display by Tobacco mosaic virus. Virology. 407(1). 7–13. 20 indexed citations
20.
Paushkin, Sergey, et al.. (2001). Itt1p, a novel protein inhibiting translation termination in Saccharomyces cerevisiae. BMC Molecular Biology. 2(1). 9–9. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026